Early Phase 1 Relapsed or Refractory Clinical Trials

2 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 1–2 of 2 trials

Recruiting

Early Phase 1

CAR 70-BCMA CAR-T Cells for the Treatment of Relapsed or Refractory Plasma Cell Neoplasms

Relapsed or Refractory Plasma Cell Neoplasms

The General Hospital of Western Theater Command20 enrolled1 locationNCT07519187

Recruiting

Early Phase 1

UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies.

CD19-positive Relapsed or Refractory B-cell Malignancies

PersonGen BioTherapeutics (Suzhou) Co., Ltd.10 enrolled1 locationNCT06092047